The reliable supply of drugs is fundamental to any healthcare system, yet shortages remain a persistent problem.
Disruptions arise from a range of causes: manufacturing failures, fluctuating demand, regulatory changes and wars. Around 60% of drug shortages are linked to manufacturing bottlenecks, while insufficient reserves of both finished products and raw ingredients continue to leave health systems like the NHS exposed.
